Helius Medical Stock (NASDAQ:HSDT)

Revenue Ownership Financials Chart Transcripts

Previous Close

$0.32

52W Range

$0.27 - $6.08

50D Avg

$0.47

200D Avg

$0.63

Market Cap

$1.85M

Avg Vol (3M)

$2.49M

Beta

1.28

Div Yield

-

HSDT Company Profile

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

21

IPO Date

Jun 27, 2014

Website

HSDT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 21	Dec 20	Dec 19
Product	$493.00K	$625.00K	$1.45M
License	-	$27.00K	$5.00K
Franchise	-	$9.00K	$37.00K

Fiscal year ends in Dec 24 | Currency in USD

HSDT Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$520.00K	$644.00K	$787.00K
Operating Income	$-13.90M	$-12.43M	$-14.76M
Net Income	$-11.74M	$-8.85M	$-12.56M
EBITDA	$-13.90M	$-12.11M	$-14.50M
Basic EPS	$-0.43	$-14.56	$-46.52
Diluted EPS	$-0.43	$-14.56	$-46.52

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q2 24Aug 12, 24 | 4:30 PM

Q1 24May 13, 24 | 4:30 PM

Q4 23Mar 28, 24 | 4:30 PM

Peer Comparison

Ticker	Company
SINT	Sintx Technologies, Inc.
RPID	Rapid Micro Biosystems, Inc.
SGHT	Sight Sciences, Inc.
RSLS	ReShape Lifesciences Inc.
SSKN	STRATA Skin Sciences, Inc.
BBLG	Bone Biologics Corporation
VVOS	Vivos Therapeutics, Inc.
NUWE	Nuwellis, Inc.
TIVC	Tivic Health Systems, Inc.
BJDX	Bluejay Diagnostics, Inc.
HSCS	Heart Test Laboratories, Inc.